GlassScriptPhysician profile
Scott Thomas Sauer
NPI 1336149145
$3,977.01
in general payments reported to CMS, 2019-2025
12 companies · $555 in 2025
The $555 reported for 2025 was less than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $729 · 2020: $2,276 · 2024: $418 · 2025: $555.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $973.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $972.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $2,067.40 | 2020-2024 | Arthrex |
| Stryker Corporation | $905.84 | 2019-2025 | Easyfuse, Ortholoc 3di Crosscheck, Ortholoc 3di |
| Novus Surgical Solutions LLC | $289.99 | 2019-2020 | |
| Peerless Surgical INC. | $178.12 | 2024-2025 | |
| Curonix LLC | $124.09 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Biotissue Holdings INC. | $114.55 | 2024 | |
| Novus Surgical Consultants | $62.53 | 2025 | |
| Smith+Nephew, INC. | $56.10 | 2024-2025 | Bone Anchors With Arthroscopic Delivery System, Grafix Pl, Stravix |
| Bioventus LLC | $52.48 | 2024-2025 | Exogen Ultrasound Bone Healing System, Durolane |
| Integra Lifesciences Corporation | $43.41 | 2019 | |
| Depuy Synthes Sales INC. | $42.40 | 2024 | Na |
| Vertex Pharmaceuticals Incorporated | $40.10 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Sauer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.